Results
100
Companies with a Future performance score of at least 3, ordered by Future performance score.
100 companies
Hims & Hers Health
Market Cap: US$5.6b
Operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally.
HIMS
US$26.71
7D
-0.9%
1Y
116.5%
Myomo
Market Cap: US$154.4m
A wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally.
MYO
US$4.65
7D
8.9%
1Y
35.2%
Establishment Labs Holdings
Market Cap: US$830.2m
A medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries.
ESTA
US$29.78
7D
-1.3%
1Y
-39.2%
VolitionRx
Market Cap: US$46.3m
A multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and diseases associated with NETosis such as sepsis in the United States and internationally.
VNRX
US$0.48
7D
-4.0%
1Y
-40.0%
Delcath Systems
Market Cap: US$396.5m
An interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe.
DCTH
US$11.96
7D
3.5%
1Y
119.4%
Predictive Oncology
Market Cap: US$8.0m
A knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of optimal cancer therapies.
POAI
US$0.96
7D
0.9%
1Y
-28.6%
PACS Group
Market Cap: US$1.4b
Through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States.
PACS
US$8.99
7D
-1.3%
1Y
-62.5%
Ontrak
Market Cap: US$6.0m
Operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States.
OTRK
US$1.54
7D
7.7%
1Y
-69.4%
IceCure Medical
Market Cap: US$64.5m
A commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors.
ICCM
US$1.12
7D
-1.8%
1Y
-8.2%
Owlet
Market Cap: US$54.5m
Provides digital parenting solutions in the United States, the United Kingdom, and internationally.
OWLT
US$3.52
7D
8.6%
1Y
-11.6%
LENSAR
Market Cap: US$162.9m
A commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System.
LNSR
US$13.84
7D
0.7%
1Y
324.5%
NEXGEL
Market Cap: US$21.1m
Manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States.
NXGL
US$2.70
7D
-4.6%
1Y
22.2%
EUDA Health Holdings
Market Cap: US$138.0m
Operates as a healthcare specialty company.
EUDA
US$3.90
7D
-2.0%
1Y
116.7%
Lifeward
Market Cap: US$15.2m
A medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally.
LFWD
US$1.48
7D
6.5%
1Y
-68.8%
Nuwellis
Market Cap: US$3.9m
A medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy.
NUWE
US$0.87
7D
-2.4%
1Y
-90.1%
Alignment Healthcare
Market Cap: US$3.5b
Operates a consumer-centric healthcare platform for seniors in the United States.
ALHC
US$18.30
7D
-6.1%
1Y
253.3%
Ekso Bionics Holdings
Market Cap: US$10.0m
Designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Europe, the Middle East, Africa, the Asia Pacific, and internationally.
EKSO
US$0.42
7D
1.4%
1Y
-64.4%
TransMedics Group
Market Cap: US$3.1b
A commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.
TMDX
US$92.25
7D
4.5%
1Y
3.4%
McKesson
Market Cap: US$87.1b
Provides healthcare services in the United States and internationally.
MCK
US$692.27
7D
-0.3%
1Y
29.3%
Penumbra
Market Cap: US$10.7b
Designs, develops, manufactures, and markets medical devices in the United States and internationally.
PEN
US$278.77
7D
0.4%
1Y
35.2%
Inspire Medical Systems
Market Cap: US$4.4b
A medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.
INSP
US$148.37
7D
1.0%
1Y
-36.6%
LifeStance Health Group
Market Cap: US$2.4b
Through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States.
LFST
US$6.37
7D
-5.1%
1Y
3.2%
Waystar Holding
Market Cap: US$6.3b
Develops a cloud-based software solution for healthcare payments.
WAY
US$36.80
7D
1.0%
1Y
n/a
Surgery Partners
Market Cap: US$2.7b
Owns and operates a network of surgical facilities and ancillary services in the United States.
SGRY
US$21.20
7D
-0.09%
1Y
-14.7%
Joint
Market Cap: US$150.2m
Operates and franchises chiropractic clinics in the United States.
JYNT
US$9.87
7D
-1.5%
1Y
-19.6%
TELA Bio
Market Cap: US$37.2m
A commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy.
TELA
US$0.92
7D
-3.9%
1Y
-79.3%
Performant Healthcare
Market Cap: US$191.9m
Provides audit, recovery, and analytics services in the United States.
PHLT
US$2.47
7D
1.2%
1Y
-7.8%
Zynex
Market Cap: US$73.8m
Designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation.
ZYXI
US$2.44
7D
11.9%
1Y
-77.7%
LHC Group
Market Cap: US$5.3b
LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States.
LHCG
US$169.81
7D
0.6%
1Y
32.1%
Simulations Plus
Market Cap: US$711.5m
Develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide.
SLP
US$35.26
7D
9.5%
1Y
-24.4%
Astrana Health
Market Cap: US$1.5b
A healthcare management company, provides medical care services in the United States.
ASTH
US$30.90
7D
-5.5%
1Y
-16.5%
InnovAge Holding
Market Cap: US$373.3m
Manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities.
INNV
US$2.91
7D
2.5%
1Y
-27.1%
GeneDx Holdings
Market Cap: US$2.7b
A genomics company, provides genetic testing services.
WGS
US$105.69
7D
7.5%
1Y
794.2%
Glaukos
Market Cap: US$5.1b
An ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally.
GKOS
US$92.61
7D
4.3%
1Y
-8.2%
DexCom
Market Cap: US$26.2b
A medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.
DXCM
US$66.86
7D
-2.5%
1Y
-51.6%
Talkspace
Market Cap: US$468.3m
Operates as a virtual behavioral healthcare company that connects patients with licensed mental health providers in the United States.
TALK
US$2.83
7D
3.7%
1Y
-7.8%